Emedastine

Generic name
Emedastine
Brand name
ATC Code
S01GX06

Emedastine

Dosages
Side effects in children
Warnings & precautions in children
Contra-indications in children

Interactions
PK
Renal impairment
References

Pharmacokinetics in children

No information

dose recommendation of formulary compared to licensed use (on-label versus off-label)

No information is present at this moment.

Available formulations

No information is present at this moment.

Dosages

Allergic conjunctivitis, vernal keratoconjunctivitis
  • Ocular
    • 3 years up to 18 years
      • 1 drop(s)/dose twice daily. in the affected eye/eyes.

Renal impaiment in children > 3 months

No information available on dose adjustment in renal impairment.

The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here

Side effects

No information is present at this moment.

The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here

Contra-indications

No information available on specific contra indications in children.

The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here

Warnings & precautions

No information available on specific warnings and precautions in children.

Interactions

The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here

DECONGESTANTS AND ANTIALLERGICS

This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.

Sympathomimetics used as decongestants
S01GA01
Other antiallergics
S01GX07
S01GX01
S01GX08
S01GX02
S01GX09

Reference

  1. Alcon Laboratories, SPC Emadine (EU/1/98/095/001-002), www.cbg-meb.nl, Geraadpleegd 27 mei 2010, http://www.ema.europa.eu/humandocs/PDFs/EPAR/emadine/emea-combined-h223nl.pdf

Changes

Therapeutic Drug Monitoring


Overdose